- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02220478
Signature Acetabular Posterior/Lateral Data Collection
September 30, 2022 updated by: Zimmer Biomet
A Prospective Controlled Study on Signature Anterior Posterior/Lateral Acetabular Cup Placement System in Total Hip Arthroplasty
The primary purpose of this pilot study is to evaluate the accuracy of cup placement between two instrumentation technologies: Cutting Guide and Conventional Instrumentation.
Study Overview
Status
Terminated
Intervention / Treatment
Detailed Description
Using a more advanced surgical technique may assist surgeons and patients in a variety of ways including identifying a specific-size for the prosthesis prior to surgery, increasing operating room efficiency, and reducing the number of traditional instruments needed.
This may reduce cost associated with the instrument inventory and instrument sterilization.
Operating time may also be reduced, potentially decreasing the patient's risk of infection.
However, before these hypotheses can be tested, it is important to fully understand the efficacy and accuracy of Signature Custom Guides and their use in Total Hip Arthroplasty.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects with one of the following indication:
- Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- Rheumatoid arthritis.
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
Additional inclusion criteria include:
- Subjects requiring primary total hip arthroplasty
- 20 to 75 years of age
- Subjects with a diagnosis of osteoarthritis or traumatic arthritis
- Subjects willing to return for follow-up evaluations.
- Subjects who can read, understand study information and give written consent without representation of a legally authorized representative.
- Bilateral patients are included if staged.
- Only Posterior Lateral Approach can be used for inclusion in this study
Exclusion Criteria:
- Exclusion criteria should be in accordance with Contraindications for the Biomet primary acetabular cup.
Absolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement.
Additional contraindications include:
- Subjects whose bony structure deviates substantially from the general norm sufficiently to require non-standard implants. Specific examples of these are total dislocation of the hip, severe coxa vera deformity, and severe forms of multiple epiphyseal dysplasia
- Subjects unable to cooperate with and complete the study
- Dementia and inability to understand and follow instructions
- Neurological conditions affecting movement
- Pregnancy
Additional exclusion criteria include:
- Surgical approach other than posterior lateral.
- Simultaneous bilateral procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Signature Cutting Guides
Patients indicated for a Posterior Lateral THA utilizing non implantable Signature Cutting Guides during surgery.
|
All patients enrolled in the study are indicated for a total hip replacement, and will receive this replacement from the surgeon via a Posterior Lateral surgical approach.
|
|
Active Comparator: Conventional Instrumentation
Patients indicated for a Posterior Lateral THA utilizing non implantable Conventional Instrumentation during surgery.
|
All patients enrolled in the study are indicated for a total hip replacement, and will receive this replacement from the surgeon via a Posterior Lateral surgical approach.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative Room Time
Time Frame: Surgery
|
Average operative time
|
Surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
August 18, 2014
First Submitted That Met QC Criteria
August 18, 2014
First Posted (Estimate)
August 20, 2014
Study Record Updates
Last Update Posted (Actual)
October 25, 2022
Last Update Submitted That Met QC Criteria
September 30, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORTHO.CR.GH24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
Yuanyuan ZhangRecruitingRheumatoid Arthritis (RA) | Rheumatoid Arthritis-Associated Interstitial Lung Disease | Difficult-to-Treat Rheumatoid ArthritisChina
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
-
David Grant U.S. Air Force Medical CenterCompleted
Clinical Trials on Posterior Lateral Approach Total Hip Arthroplasty
-
Ochsner Health SystemRecruitingOsteoarthritis (OA) of the HipUnited States
-
Nova Scotia Health AuthorityActive, not recruiting
-
OrthoCarolina Research Institute, Inc.Completed
-
Sorlandet Hospital HFUnknown
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHip OsteoarthritisNorway
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria
-
Barrett, William, M.D.Johnson & JohnsonCompletedOsteoarthritis of the HipUnited States
-
Zimmer BiometAarhus University HospitalCompletedArthritis | Avascular NecrosisDenmark
-
University Hospital, Clermont-FerrandCompletedSurgical Approach | Humeral Fracture | Aged Patient | Reversed Total Shoulder ArthroplastyFrance
-
The Orthopaedic Research & Innovation FoundationActive, not recruitingOsteo Arthritis Shoulders | Total Shoulder ArthroplastyUnited States